Articoli correlati a Analyzing T Cell Responses: How to analyze cellular...

Analyzing T Cell Responses: How to analyze cellular immune responses against tumor associated antigens - Brossura

 
9789048169115: Analyzing T Cell Responses: How to analyze cellular immune responses against tumor associated antigens

Sinossi

Active specific immunotherapy is a promising but investigational modality in the management of cancer patients. Currently, several different cancer vaccine formulations such as peptides, proteins, antigen-pulsed dendritic cells, whole tumor cells, etc. in combination with various adjuvants and carriers are being evaluated in clinical trials (1-3). To determine the optimal cancer vaccine strategy, a surrogate immunological end-point that correlates with clinical outcome needs to be defined, since it would facilitate the rapid comparison of these various formulations. Traditional immunological assays such as ELISA, proliferation and cytotoxicity assays can detect immune responses in vaccinated patients but are not quantitative. In contrast, novel assays such as enzyme-linked immunospot (ELISPOT) assay, intracellular cytokine assay and tetramer assay can quantitate the frequency of antigen-specific T cells. Of these, the ELISPOT assay has the 5 lowest detection limit with 1/10 peripheral blood mononuclear cells (PBMC) and has been determined to be one of the most useful assays to evaluate immune response to cancer vaccines (4). However, the IFN-? ELISPOT assay is not an exclusive measure of cytotoxic T-lymphocyte (CTL) activity as non-cytotoxic cells can also secrete IFN-?. Additionally, CTL with lytic activity do not always secrete IFN-? (5). A more relevant approach to assess functional activity of cytotoxic lymphocytes would be to measure the secretion of molecules that are associated with lytic activity. One of the major mechanisms of cell-mediated cytotoxicity involves exocytosis of cytoplasmic granules from the effector toward the target cell.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

Recensione

From the reviews of the first edition:

"This book represents the first comprehensive description, and evaluation of the most important assays utilized to monitor immune responses against tumor associated antigens. ... Specifically tailored to the needs of clinical researchers, basic science investigators, and biotechnology innovators, this book provides information that is both sufficiently detailed and eloquently succinct. All discussions are substantiated with a comprehensive literature review. ... Analyzing T Cell Responses provides the most substantial and extensive review of immune response-monitoring techniques available to date." (Melanie Hayden, Stephanie Schroter and Boris Minev, Angiogenesis, Vol. 9, 2006)

Contenuti

Chapter 1: Monitoring Antigen-Specific T Cell Responses; Dirk Nagorsen, Francesco M. Marincola

Chapter 2: Tumor Associated Antigens; Paul F. Robbins

Chapter 3: Immune Escape, Tumor induced immune suppression and immune escape: Mechanisms and Possible Solutions; Theresa L. Whiteside, Michael Campoli, Soldano Ferrone

Chapter 4: Virus Specific T-Cell Responses; Victor Appay

Chapter 5: Cytotoxicity Assays Killer Lymphocytes in Cancer; Gideon Berke & William R. Clark

Chapter 6: Monitoring T Cell Proliferation; Philip D. Hodgkin, Edwin D. Hawkins, Jhaguaral Hasbold, Amanda V. Gett, Elissa K. Deenick, Hilary F. Todd & Mirja Hommel

Chapter 7: Elispot Assay, Assessment of Cellular Immune Responses to Anti-Cancer Vaccines; Theresa L. Whiteside

Chapter 8: Modified Elispot, Modifications of the Elispot Assay for T Cell Monitoring in Cancer Vaccine Trials; Anatoli Malyguine

Chapter 9: Intracellular Cytokine Staining, Cytokine flow cytometry for characterization of tumor-specific T cell responses; Carmen Scheibenbogen, Anne Letsch, Anne Marie Asemissen, Alexander Schmittel, Eckhard Thiel & Ulrich Keilholz

Chapter 10: Cytometric Cytokine Secretion Assay, Detection and Isolation of Antigen-Specific T Cells; Mario Assenmacher

Chapter 11: Peptide/MHC Tetramer Analysis; Peter P. Lee & Francesco M. Marincola

Chapter 12: In Situ MHC Tetramer Staining, In Situ Tetramers; Pamela J. Skinner

Chapter 13: MHC-IG Dimeric Molecules, Dimers - MHC-Ig dimeric molecules for the analysis of antigen-specific T cell responses; Tim F. Greten & Firouzeh Korangy

Chapter 14: TCR Analyses, T-cell receptor CDR3 analysis: Molecular fingerprinting of the T-cell receptor repertoire; Markus J. Maeurer

Chapter 15: Peptide/HLA-GFP Complexes, Detection of Antigen-Specific T Cells by Acquisition of Peptide/Hla-Gfp Complexes; Utano Tomaru, Yoshihisa Yamano & Steven Jacobson

Chapter 16: QRT-PCR, Quantitative RT-PCR for the Analysis of T cell Responses in Immunized Cancer Patients; Udai S. Kammula

Chapter 17: Microarrays, Gene expression profiling approaches for the monitoring of anti-cancer immune responses; Ena Wang

Concluding Remarks; Dirk Nagorsen & Francesco M. Marincola

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Altre edizioni note dello stesso titolo

9781402036224: Analyzing T Cell Responses: How to Analyze Cellularimmune Responses Against Tumor Associated Antigens

Edizione in evidenza

ISBN 10:  1402036221 ISBN 13:  9781402036224
Casa editrice: Kluwer Academic Pub, 2005
Rilegato

Risultati della ricerca per Analyzing T Cell Responses: How to analyze cellular...

Foto dell'editore

Editore: Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
Nuovo Brossura

Da: Lucky's Textbooks, Dallas, TX, U.S.A.

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. Codice articolo ABLIING23Apr0316110338153

Contatta il venditore

Compra nuovo

EUR 158,08
Convertire valuta
Spese di spedizione: EUR 3,43
In U.S.A.
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Foto dell'editore

Editore: Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
Nuovo Brossura

Da: Ria Christie Collections, Uxbridge, Regno Unito

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. In. Codice articolo ria9789048169115_new

Contatta il venditore

Compra nuovo

EUR 158,22
Convertire valuta
Spese di spedizione: EUR 13,72
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Francesco M. Marincola
ISBN 10: 9048169119 ISBN 13: 9789048169115
Nuovo Taschenbuch
Print on Demand

Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Active specific immunotherapy is a promising but investigational modality in the management of cancer patients. Currently, several different cancer vaccine formulations such as peptides, proteins, antigen-pulsed dendritic cells, whole tumor cells, etc. in combination with various adjuvants and carriers are being evaluated in clinical trials (1-3). To determine the optimal cancer vaccine strategy, a surrogate immunological end-point that correlates with clinical outcome needs to be defined, since it would facilitate the rapid comparison of these various formulations. Traditional immunological assays such as ELISA, proliferation and cytotoxicity assays can detect immune responses in vaccinated patients but are not quantitative. In contrast, novel assays such as enzyme-linked immunospot (ELISPOT) assay, intracellular cytokine assay and tetramer assay can quantitate the frequency of antigen-specific T cells. Of these, the ELISPOT assay has the 5 lowest detection limit with 1/10 peripheral blood mononuclear cells (PBMC) and has been determined to be one of the most useful assays to evaluate immune response to cancer vaccines (4). However, the IFN- ELISPOT assay is not an exclusive measure of cytotoxic T-lymphocyte (CTL) activity as non-cytotoxic cells can also secrete IFN- . Additionally, CTL with lytic activity do not always secrete IFN- (5). A more relevant approach to assess functional activity of cytotoxic lymphocytes would be to measure the secretion of molecules that are associated with lytic activity. One of the major mechanisms of cell-mediated cytotoxicity involves exocytosis of cytoplasmic granules from the effector toward the target cell. 328 pp. Englisch. Codice articolo 9789048169115

Contatta il venditore

Compra nuovo

EUR 160,49
Convertire valuta
Spese di spedizione: EUR 23,00
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Quantità: 2 disponibili

Aggiungi al carrello

Foto dell'editore

Editore: Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
Nuovo Brossura

Da: California Books, Miami, FL, U.S.A.

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. Codice articolo I-9789048169115

Contatta il venditore

Compra nuovo

EUR 194,82
Convertire valuta
Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Foto dell'editore

Editore: Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
Nuovo Brossura

Da: Books Puddle, New York, NY, U.S.A.

Valutazione del venditore 4 su 5 stelle 4 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. pp. 328. Codice articolo 262171990

Contatta il venditore

Compra nuovo

EUR 195,02
Convertire valuta
Spese di spedizione: EUR 3,43
In U.S.A.
Destinazione, tempi e costi

Quantità: 4 disponibili

Aggiungi al carrello

Foto dell'editore

Editore: Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
Nuovo Brossura
Print on Demand

Da: Majestic Books, Hounslow, Regno Unito

Valutazione del venditore 4 su 5 stelle 4 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. Print on Demand pp. 328 49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam. Codice articolo 5675913

Contatta il venditore

Compra nuovo

EUR 206,30
Convertire valuta
Spese di spedizione: EUR 7,44
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

Quantità: 4 disponibili

Aggiungi al carrello

Foto dell'editore

Nagorsen Dirk Marincola Francesco M.
Editore: Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
Nuovo Brossura
Print on Demand

Da: Biblios, Frankfurt am main, HESSE, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. PRINT ON DEMAND pp. 328. Codice articolo 182171996

Contatta il venditore

Compra nuovo

EUR 208,60
Convertire valuta
Spese di spedizione: EUR 9,95
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Quantità: 4 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Francesco M. Marincola
ISBN 10: 9048169119 ISBN 13: 9789048169115
Nuovo Taschenbuch
Print on Demand

Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Active specific immunotherapy is a promising but investigational modality in the management of cancer patients. Currently, several different cancer vaccine formulations such as peptides, proteins, antigen-pulsed dendritic cells, whole tumor cells, etc. in combination with various adjuvants and carriers are being evaluated in clinical trials (1-3). To determine the optimal cancer vaccine strategy, a surrogate immunological end-point that correlates with clinical outcome needs to be defined, since it would facilitate the rapid comparison of these various formulations. Traditional immunological assays such as ELISA, proliferation and cytotoxicity assays can detect immune responses in vaccinated patients but are not quantitative. In contrast, novel assays such as enzyme-linked immunospot (ELISPOT) assay, intracellular cytokine assay and tetramer assay can quantitate the frequency of antigen-specific T cells. Of these, the ELISPOT assay has the 5 lowest detection limit with 1/10 peripheral blood mononuclear cells (PBMC) and has been determined to be one of the most useful assays to evaluate immune response to cancer vaccines (4). However, the IFN- ELISPOT assay is not an exclusive measure of cytotoxic T-lymphocyte (CTL) activity as non-cytotoxic cells can also secrete IFN- . Additionally, CTL with lytic activity do not always secrete IFN- (5). A more relevant approach to assess functional activity of cytotoxic lymphocytes would be to measure the secretion of molecules that are associated with lytic activity. One of the major mechanisms of cell-mediated cytotoxicity involves exocytosis of cytoplasmic granules from the effector toward the target cell.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 328 pp. Englisch. Codice articolo 9789048169115

Contatta il venditore

Compra nuovo

EUR 160,49
Convertire valuta
Spese di spedizione: EUR 60,00
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Francesco M. Marincola
Editore: Springer Netherlands, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
Nuovo Taschenbuch

Da: AHA-BUCH GmbH, Einbeck, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Active specific immunotherapy is a promising but investigational modality in the management of cancer patients. Currently, several different cancer vaccine formulations such as peptides, proteins, antigen-pulsed dendritic cells, whole tumor cells, etc. in combination with various adjuvants and carriers are being evaluated in clinical trials (1-3). To determine the optimal cancer vaccine strategy, a surrogate immunological end-point that correlates with clinical outcome needs to be defined, since it would facilitate the rapid comparison of these various formulations. Traditional immunological assays such as ELISA, proliferation and cytotoxicity assays can detect immune responses in vaccinated patients but are not quantitative. In contrast, novel assays such as enzyme-linked immunospot (ELISPOT) assay, intracellular cytokine assay and tetramer assay can quantitate the frequency of antigen-specific T cells. Of these, the ELISPOT assay has the 5 lowest detection limit with 1/10 peripheral blood mononuclear cells (PBMC) and has been determined to be one of the most useful assays to evaluate immune response to cancer vaccines (4). However, the IFN- ELISPOT assay is not an exclusive measure of cytotoxic T-lymphocyte (CTL) activity as non-cytotoxic cells can also secrete IFN- . Additionally, CTL with lytic activity do not always secrete IFN- (5). A more relevant approach to assess functional activity of cytotoxic lymphocytes would be to measure the secretion of molecules that are associated with lytic activity. One of the major mechanisms of cell-mediated cytotoxicity involves exocytosis of cytoplasmic granules from the effector toward the target cell. Codice articolo 9789048169115

Contatta il venditore

Compra nuovo

EUR 164,49
Convertire valuta
Spese di spedizione: EUR 62,80
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello

Foto dell'editore

Nagorsen, Dirk (Editor) / Marincola, Francesco M. (Editor)
Editore: Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
Nuovo Paperback

Da: Revaluation Books, Exeter, Regno Unito

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Paperback. Condizione: Brand New. 325 pages. 9.25x6.10x0.77 inches. In Stock. Codice articolo x-9048169119

Contatta il venditore

Compra nuovo

EUR 233,31
Convertire valuta
Spese di spedizione: EUR 14,32
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

Quantità: 2 disponibili

Aggiungi al carrello